Palatin Technologies
PTN
#10644
Rank
NZ$24.74 M
Marketcap
NZ$13.91
Share price
-1.42%
Change (1 day)
N/A
Change (1 year)

Palatin Technologies (PTN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$4.55 Million

According to Palatin Technologies's latest financial reports the company's total liabilities are NZ$4.55 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Palatin Technologies - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-06-30NZ$13.2 M-25.8%
2024-06-30NZ$17.79 M-45.2%
2023-06-30NZ$32.47 M2.34%
2022-06-30NZ$31.73 M25.83%
2021-06-30NZ$25.21 M233.33%
2020-06-30NZ$7.56 M21.52%
2019-06-30NZ$6.22 M-65.02%
2018-06-30NZ$17.79 M-78.98%
2017-06-30NZ$84.68 M112.46%
2016-06-30NZ$39.85 M56.64%
2015-06-30NZ$25.44 M704.88%
2014-06-30NZ$3.16 M16.72%
2013-06-30NZ$2.7 M-38.76%
2012-06-30NZ$4.42 M22.91%
2011-06-30NZ$3.59 M-18.93%
2010-06-30NZ$4.43 M-71.21%
2009-06-30NZ$15.42 M-6.69%
2008-06-30NZ$16.52 M-47.61%
2007-06-30NZ$31.54 M-12.15%
2006-06-30NZ$35.9 M-5.32%
2005-06-30NZ$37.92 M188.3%
2004-06-30NZ$13.15 M88.43%
2003-06-30NZ$6.98 M-7.59%
2002-06-30NZ$7.55 M31.9%
2001-06-30NZ$5.72 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$207.22 B 4,545,554.77%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$115.34 B 2,530,069.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$2.59 B 56,813.72%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
NZ$5.7 M 25.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.92 B 20,207.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$1.48 B 32,544.13%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$4.53 M-0.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.61 B 13,413.97%๐Ÿ‡บ๐Ÿ‡ธ USA